Introduction The indication for treatment with a middle ear implant is primarily for patients with chronic hearing loss. The variance in middle ear pathology and the associated need to adapt the strategy for coupling the FMT to the ossicles is a constant challenge. The present study focuses on patients with postinflammatory meatal fibrosis (PIMF)
No takes yet. Share an insight, caveat, or question.
Diaz et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: